Liver Cancer Clinical Trials

A listing of Liver Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 722 clinical trials
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Phase 1, first-in-human, open label study of CAR macrophages in HER2 overexpressing solid tumors.

breast cancer
erbb2
bone marrow procedure
primary cancer
HER2
  • 0 views
  • 24 Mar, 2022
  • 5 locations
18F-FAPI PET in the Diagnosis of Liver Fibrosis

It is an open label observation clinical trial, all participants are chronic liver disease. The investigators deem to make a novel evaluate criteria to hepatic fibrosis. The point of the clinical trial is to evaluate the novel biomaker 18F-FAPI-04 by PET-CT scan in the evaluation of the hepatic fibrosis.

fibrosis
liver disease
biopsy of liver
hepatitis
hepatic fibrosis
  • 0 views
  • 12 Mar, 2022
  • 1 location
Patient-Derived Xenografts to Reduce Cancer Health Disparities

This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.

bladder tumor
bladder cancer
lung cancer
primary cancer
cancer
  • 0 views
  • 18 Jul, 2021
  • 2 locations
Clinical Characteristics, Natural Outcome and Treatment Optimization of Refractory

Refractory hepatitis B is to point to although standard application nucleoside (acid) analogue treatment undertakes primary treatment and two strengthen treatment, but existence is persistent viremia. Currently, there is no consensus on salvage therapy for patients who remain virus-positive after a second round of antiviral therapy. This is the first …

antiviral drugs
  • 0 views
  • 29 May, 2022
  • 13 locations
The Short-term Efficacy of Novel NTDP-RFA in the Treatment of Small HCC With Cirrhosis.

To evaluate the short-term efficacy of novel no-touch combined directional perfusion radiofrequency ablation in the treatment of small hepatocellular carcinoma with cirrhosis.

  • 0 views
  • 25 Jan, 2021
  • 1 location
Prospective Analysis of In Vivo Laparoscopic Microwave Ablation Thermodynamics (MWA)

To prospectively collect and evaluate pre-operative, intra-operative, and post-operative variables for all patients undergoing surgical microwave ablation. All patients who have a surgical microwave ablation with the Neuwave system will be added to the database after their treatment and procedures have been completed.

  • 0 views
  • 08 Aug, 2022
  • 1 location
Stopping Antiviral Treatment in Chronic Hepatitis B

Chronic hepatitis B (CHB) infection affected 292 million individuals in the world, translating to about 3.9% of global prevalence. Up to 40% of patients with CHB will develop liver-related complications. Many patients require long-term oral antiviral therapy since off-treatment sustained virological control can only be achieved in a minority of …

cirrhosis
tenofovir
hepatitis
entecavir
antiviral therapy
  • 0 views
  • 16 Oct, 2021
  • 1 location
Pathological Fracture in Potentially Unstable Spinal Metastases of Breast Cancer

The purpose of this study is to identify potential risk factors for and determine the rate of pathological fracture for patients which having spine metastases from breast cancer and be defined as potentially unstable (SINS 7-12) according to the Spinal Instability Neoplastic Score (SINS). The investigators' analysis will provide robust …

breast cancer
metastasis
cancer
  • 0 views
  • 25 Jan, 2021
  • 1 location
Alpha-1 Antitrypsin Deficiency Adult Liver Study

The investigators hypothesize that there is liver injury (inflammation, fibrosis, cirrhosis) in adults with Alpha-1 Antitrypsin Deficiency (AATD), which is asymptomatic, under-recognized, and undiagnosed. In addition, the investigators believe that the genetic and environmental factors that play an important role in the development of alpha-1 antitrypsin (AAT) liver disease, can …

alpha1-proteinase inhibitor (human)
fibrosis
liver study
cirrhosis
liver disease
  • 262 views
  • 21 Mar, 2022
  • 3 locations
Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study

Acetaminophen (APAP) is the most commonly used NSAIDS in clinic, and it is also a common cause of drug-induced liver injury (DILI). In 2012, the proportion of DILI caused by APAP in the United States was 51%, while in Asia, it was only 7.10%. Previously, a small cohort study in …

  • 0 views
  • 25 Jul, 2021
  • 1 location